Showing 71-80 of 3001 results for "".
PROs in MS: A New Era of Patient-Centric Care
https://practicalneurology.com/programs/cme/pros-in-ms-a-new-era-of-patient-centric-care/32234/Tune in to learn more about the use of high-efficacy DMTs in multiple sclerosis.A Once-Daily Oral Therapy for Relapsing MS
https://practicalneurology.com/diseases-diagnoses/ms-immune-disorders/a-once-daily-oral-therapy-for-relapsing-ms/31907/Data from a phase 3, head-to-head study support the efficacy and safety profile of this DMT.MS Minute: Update on BTK Inhibitors for Multiple Sclerosis—A New Treatment That Brings New Hope
https://practicalneurology.com/diseases-diagnoses/ms-immune-disorders/update-on-btk-inhibitors-for-multiple-sclerosis-a-new-treatment-that-brings-new-hope/40007/BTK inhibitors are the first class of medications to slow disability progression in secondary progressive multiple sclerosis without clinical relapses.Patient-Centric Innovations in MS Care: High-Efficacy DMTs, Cognition, and Special Patient Populations
https://practicalneurology.com/programs/cme/patient-centric-innovations-in-ms-care-high-efficacy-dmts-cognition-and-special-patient-populations/29171/Tune in to learn more about the use of high-efficacy DMTs in multiple sclerosis.Patient-Centric Innovations in MS Care: High-Efficacy DMT’s, Cognition, and Special Patient Populations
https://practicalneurology.com/programs/cme/patient-centric-innovations-in-ms-care-high-efficacy-dmts-cognition-and-special-patient-populations/29172/Learn more about the use of high-efficacy DMTs in multiple sclerosis.MS Minute: Cognitive Dysfunction in People Living with Multiple Sclerosis
https://practicalneurology.com/diseases-diagnoses/ms-immune-disorders/ms-minute-cognitive-dysfunction-in-people-living-with-multiple-sclerosis/32170/Cognitive deficits are common in people with multiple sclerosis and affect multiple domains, including employment, activities of daily living, and relationships.Seeking Breakthroughs: The Industry Perspective
https://practicalneurology.com/diseases-diagnoses/alzheimer-disease-dementias/the-industry-perspective/30192/A roundtable discussion with Gregory Went, PhD, Adamas Pharmaceuticals; Lynn Kramer, MD, Eisai; Paulo Fontoura, MD, PhD, Genentech/Roche; Justin Gover, BSc, MBA, GW Pharmaceuticals; Marc Kamin, MD, SK Life Sciences; and Mike Davis, BSc, MBA, UCBLearning, Laughing, and Living with Multiple Sclerosis
https://practicalneurology.com/diseases-diagnoses/ms-immune-disorders/learning-laughing-and-living-with-multiple-sclerosis/37228/Ardra Shephard, a musician, author, fashion-show TV host, podcaster, and MS advocate, discusses her experiences living with MS, including how she uses her story to educate and encourage others living with MS. She is joined by Jiwon Oh, MD, Medical Director of the Barlo Multiple Sclerosis Program atPersonalized Care for Diverse MS Populations: Special Populations Equal Special Care
https://practicalneurology.com/programs/cme/personalized-care-for-diverse-ms-populations-special-populations-equal-special-care/32231/Tune in to learn more about the use of high-efficacy DMTs in multiple sclerosis.Optic Neuritis: Update on Diagnosis, Management, and Long-term Follow-up
https://practicalneurology.com/columns/practice-management/PN1009_02-php/30879/Specialists share insights on diagnostic tools, prospects for neuroprotective therapies, and the risk of MS.